{"from": "gobernator", "text": "Dame el precio actual de ALL (Allstate). Usa tu price_checker.", "ts": "2026-02-10T09:53:35.625043+00:00"}
{"from": "especialista", "text": "**ALL (Allstate):** $199.94 (EUR 167.73)\n\n- P/E: 5.3\n- Yield: 2.2%\n- 52w High: $216.75 | 52w Low: $176.00\n- Market Cap: $52.3B\n\nPrecio actual vs tu avg cost de $196.00 → P&L: **+2.0%**. vs adversarial FV de $234 → MoS: **14.6%**.", "ts": "2026-02-10T09:53:51.343637+00:00"}
{"from": "gobernator", "text": "Necesito que actualices la thesis de ADBE. El risk-sentinel detectó un gap: hay un tema FTC/DOJ lawsuit que no está reflejado en la thesis actual. Investiga qué está pasando con ADBE respecto a reguladores (FTC, DOJ, antimonopolio), evalúa el impacto en la thesis, y actualiza el FV y QS si es necesario. Usa tus herramientas — quality_scorer, web search, valuation tools. Quiero una thesis completa actualizada, no un análisis parcial.", "ts": "2026-02-10T10:25:47.379076+00:00"}
{"from": "especialista", "text": "Thesis ADBE actualizada a v2.0. Resumen de cambios:\n\n---\n\n## ADBE Thesis v2.0 - Resumen de Cambios\n\n### Riesgo FTC/DOJ descubierto\n- **Caso:** U.S. v. Adobe Inc. (N.D. Cal.) — ROSCA violation (dark patterns en cancelaciones)\n- **Timeline:** Filed Jun 2024 → Motion to Dismiss **DENEGADA** May 2025 → **JURY TRIAL Oct 19, 2026**\n- **Alegaciones:** ETF oculto (50% pagos restantes), proceso de cancelacion disenado para disuadir, 2 ejecutivos nombrados personalmente\n- **Class action paralela** filed Aug 2025\n- **False Claims Act:** $3M settled 2023 (resuelto, inmaterial)\n\n### Impacto financiero estimado\n| Concepto | Rango |\n|----------|-------|\n| Multa civil one-time | $150M - $1B |\n| Expected cost (prob-weighted) | ~$470M |\n| Churn drag anual (permanente) | ~$240M/yr |\n| **Total annual impact** | **~$334M/yr (3.4% revenue)** |\n\n### Cambios en thesis\n\n| Metrica | v1.0 | v2.0 | Delta |\n|---------|------|------|-------|\n| QS Tool | 76 | 76 | = |\n| **QS Ajustado** | 76 | **73** | **-3** (FTC risk) |\n| Tier | A | **B borderline** | Downgraded |\n| Revenue growth | 7-8% | **6.5-7.5%** | -0.5pp churn drag |\n| FV Weighted | $394 | **$390** | -1% |\n| FV Expected Value | $385 | **$370** | -3.9% |\n| Bear case | $260 | **$240** | -7.7% |\n| MoS actual | 31% | **31.6%** | Slight improvement (price dropped) |\n\n### Nuevos elementos\n- **Kill Condition #6:** FTC trial loss + mandatory one-click + churn >5pp\n- **Seccion regulatoria completa:** Timeline, alegaciones, impacto financiero, escenarios\n- **Calendario:** 3 fechas criticas (Sep 24, Oct 7, Oct 19 2026)\n- **Exit plan actualizado:** HOLD through trial, TRIM >$350, ADD only <$240\n\n### Veredicto: **HOLD** (conviction MEDIUM)\nEl FTC es riesgo MATERIAL pero no kill condition. MoS del 31.6% absorbe el escenario base. No recomiendo ADD hasta que haya claridad del trial (Oct 2026) o precio <$240.", "ts": "2026-02-10T10:32:09.249749+00:00"}
{"from": "gobernator", "text": "Ahora necesito que actualices la thesis de GL (Globe Life). El risk-sentinel la marcó como yellow porque el SEC y DOJ cerraron sus investigaciones sin acción (Jul 2025). Esto debería ser positivo para la thesis — el descuento por riesgo regulatorio debería reducirse o eliminarse. Investiga si hay novedades recientes sobre GL (Fuzzy Panda, seguimiento del caso, resultados financieros recientes, guidance) y actualiza la thesis con FV revisado, QS actualizado, y standing orders si procede. Usa tus herramientas completas.", "ts": "2026-02-10T10:32:19.151395+00:00"}
{"from": "especialista", "text": "Thesis GL actualizada a v3.0. Resumen de cambios:\n\n---\n\n## GL Thesis v3.0 - Resumen de Cambios\n\n### Catalysts positivos integrados\n\n| Factor | Antes | Ahora | Impacto |\n|--------|-------|-------|---------|\n| SEC investigation | \"Recently cleared\" | **7 meses cleared, embedded** | Risk premium reducido |\n| DOJ investigation | \"Recently cleared\" | **7 meses cleared, no enforcement** | Risk premium reducido |\n| FY2025 operating EPS | $14 estimado | **$14.52 actual (above midpoint)** | Confirms earnings power |\n| FY2026 guidance | ~$15 expected | **$14.95-$15.65 (mid $15.30)** | +5% EPS growth |\n| Book value/share | $70.84 | **$74.17 (+4.7%)** | Higher P/B-based FV |\n| Premium growth 2026 | N/A | **+7-8% guided** | Strong topline |\n| Buybacks FY25 | Active | **5.4M shares @$126 avg** | Excellent capital allocation at crisis prices |\n| Analyst targets | Mixed | **JPM $181, Truist $180** | Positive convergence |\n\n### Riesgo residual\n- **4 class actions** still active, no settlement. Legal costs immaterial ($0.04/share Q4)\n- **Fuzzy Panda** \"stands by\" claims despite federal clearances (expected behavior)\n- **Investment income** declining -16% Q4 YoY (rates sensitivity)\n\n### Cambios en thesis\n\n| Metrica | v2.0 | Adversarial | v3.0 | Delta vs v2.0 |\n|---------|------|-------------|------|---------------|\n| QS Tool | 52 | 52 | 52 | = |\n| **QS Ajustado** | 52 (Tier C) | 52 | **55 (Tier B borderline)** | **+3** |\n| Fair Value | $174 | $185 | **$191** | **+9.8%** |\n| MoS | 17.6% | ~24% | **25.9%** | **+8.3pp** |\n| Conviction | medium-low | medium-low | **medium** | Upgraded |\n| P/E applied | 11.5x | ~12x | **12.5x** | Reduced Fuzzy Panda discount |\n| Standing order | ADD $130 | — | **ADD $125** | Lowered 3.8% (more conservative) |\n\n### Ficheros actualizados\n- `thesis/active/GL/thesis.md` — v3.0 completa\n- `portfolio/current.yaml` — conviction, FV, exit_plan, last_review\n- `state/system.yaml` — QS entry, calendar events, standing order, adversarial tracker\n\n### Veredicto: **HOLD** (conviction MEDIUM, upgraded from medium-low)\nSEC/DOJ clearance es el catalizador positivo mas importante desde apertura de posicion. FV $191 con MoS 25.9% es adecuado. Standing order ADD a $125 (MoS 34.5%, cerca del promedio de buyback de management a $126).", "ts": "2026-02-10T10:38:36.833201+00:00"}
{"from": "gobernator", "text": "Siguiente tarea: actualizar la thesis de VICI Properties. Es v2.0 del 3 de febrero y el risk-sentinel la marcó ORANGE — necesita revisión. Investiga novedades recientes (resultados, guidance, pipeline de adquisiciones, estado del mercado de gaming/casinos, tipos de interés y su impacto en REITs), y actualiza la thesis completa con FV revisado, QS recalculado con quality_scorer, kill conditions actualizadas. Usa tus herramientas.", "ts": "2026-02-10T10:54:28.929997+00:00"}
{"from": "especialista", "text": "VICI thesis v3.0 complete. Here's the summary:\n\n---\n\n## VICI Properties — Thesis v3.0 (Risk-Sentinel ORANGE Resolved)\n\n### Fair Value: $33.75 → $29.00 (-14.1%)\n\n**Bridge** (-$4.75):\n- **Caesars Regional lease 1.03x coverage** (-$1.80): 25% of VICI's NOI at risk of rent reduction. JP Morgan, Evercore, Wells Fargo all flagging. Multi-part renegotiation likely (rent cut + asset sale + lease extension to 2045). Added **Kill Condition #7**: rent cut >10% without adequate compensation.\n- **LV tourism correction** (-$1.20): Thesis v2.0 claimed \"42M+ visitors, record\" — actual YTD Nov 2025 was 35.4M (annualized ~38.6M), declining 7-9% YoY. Airport traffic -9% H1 2025. Factual error corrected.\n- **Multiple compression** (-$1.00): Three independent analyst downgrades in Q4 2025 (Evercore $36→$32, Wells Fargo $36→$32, Scotiabank lowered). P/AFFO reduced from 14x to 12.5x.\n- **Acquisitions offset** (+$0.25): Golden Entertainment ($1.16B, $87M/yr rent) + Northfield Park ($53M/yr rent).\n\n### Quality Score: Tool 54 (Tier C) → REIT-Adjusted ~60 (Tier B)\n- v2.0 claimed 8/10 custom Tier A — overclaimed by ~2 full tiers\n- REIT-adj down from ~62 to ~60: Moat penalized (-2) because Caesars Regional proves \"tenant can't walk away\" ≠ \"tenant can afford rent\"\n\n### Valuation Methods:\n| Method | FV | Weight |\n|--------|-----|--------|\n| DDM (g=3.5%, Ke=10%) | $28.66 | 30% |\n| NAV (7.0% cap, Caesars-adjusted) | $26.06 | 30% |\n| P/AFFO (12.5x 2025 AFFO) | $29.63 | 40% |\n| **Weighted** | **$28.27** | |\n| **Scenario EV** | **$30.45** | |\n| **Final (conservative avg)** | **$29.00** | |\n\n### MoS at current $29.06: **-0.2% (NONE)**\n\n### Verdict: HOLD ON PROBATION (LOW conviction)\n- **TIME-BOUND**: Through Feb 25 earnings (15 days)\n- Post-earnings decision framework defined in thesis\n- SELL if: AFFO guidance <$2.35, rent cut >10% without compensation\n- TRIM at: $32\n- Q4 2025 will reveal Caesars rent renegotiation status and FY2026 guidance\n\n### Files Updated:\n- `thesis/active/VICI/thesis.md` — Complete rewrite v3.0\n- `portfolio/current.yaml` — FV, last_review, exit_plan\n- `state/system.yaml` — QS entry, calendar event, adversarial tracker, position kill conditions", "ts": "2026-02-10T11:03:20.898677+00:00"}
{"from": "gobernator", "text": "Siguiente: actualizar la thesis de DTE.DE (Deutsche Telekom). Es v2.0 del 3 de febrero, tiene earnings el 26 de febrero y está en risk-sentinel YELLOW. Investiga novedades recientes (resultados Q3/Q4 si hay, guidance, evolución T-Mobile US, deuda, regulación europea, competencia), y actualiza la thesis completa con FV revisado, QS recalculado con quality_scorer, kill conditions y preparación pre-earnings. Usa tus herramientas.", "ts": "2026-02-10T11:03:30.321924+00:00"}
{"from": "especialista", "text": "DTE.DE thesis v3.0 complete. Here's the summary:\n\n---\n\n## Deutsche Telekom (DTE.DE) — Thesis v3.0 (Risk-Sentinel YELLOW + Pre-Earnings)\n\n### Fair Value: EUR 37.50 → EUR 34.00 (-9.3%)\n\n**Bridge** (-EUR 3.50):\n- **QS overclaimed by 3 tiers** (-EUR 2.00): Custom 10/10 Tier A → Tool 48 Tier C. Lower appropriate multiples (EV/EBITDA 6.5x vs 7x, P/E 14x vs 16x).\n- **Revenue CAGR actual 1.8% vs claimed 4%** (-EUR 0.50): Growth driven by TMUS, not organic EU business.\n- **ROIC spread negative (-0.7pp)** (-EUR 0.50): Telecom structural issue — capex intensity means value creation is marginal.\n- **Offset by updated guidance** (+EUR 0.50): EBITDA AL EUR 45.3B (raised), FY2026 EPS EUR 2.50 (company target), EUR 2B buyback 2026.\n\n### Quality Score: Tool 48 (Tier C) — NO adjustment warranted\n- Unlike VICI, DTE's low score reflects genuine structural characteristics\n- Telecom IS a low-ROIC, high-leverage, commodity-pricing business\n- Tool correctly penalizes: ROIC spread -0.7pp, leverage 3.3x, moat score 7/25\n\n### Valuation Methods:\n| Method | FV | Weight |\n|--------|-----|--------|\n| EV/EBITDA (6.5x on EUR 45.3B) | EUR 34.03 | 40% |\n| P/E 2026E (14x on EUR 2.50) | EUR 35.00 | 35% |\n| SOTP (adjusted midpoint) | EUR 33.00 | 25% |\n| **Weighted** | **EUR 34.00** | |\n\n### MoS at EUR 30.41: **10.5%** (positive but thin for Tier C)\n### Forward expected return: ~14% (MoS + 3.3% dividend + EPS growth)\n### Verdict: HOLD MEDIUM conviction\n\n### Risk-Sentinel YELLOW: Net Neutrality\n- Complaint filed Apr 2025 with Bundesnetzagentur. No ruling yet.\n- EU Digital Networks Act (Jan 2026) may actually help DTE by loosening rules.\n- Probability of material harm: 10-15%. No FV adjustment.\n\n### Critical near-term catalyst: T-Mobile US Capital Markets Day TODAY (Feb 11)\n- TMUS is 63.5% of DTE's equity value\n- Q4 2025 results + 2026-2027 targets\n- Will pre-seed DTE's earnings context for Feb 26\n\n### Pre-Earnings Framework (Feb 26) defined:\n- FY2025 met + FY2026 EPS EUR 2.50 confirmed → HOLD\n- FY2025 beat + above-consensus guidance → consider FV upgrade to EUR 35-36\n- FY2025 miss or FY2026 EPS <EUR 2.30 → TRIM 50%\n- Dividend cut → SELL\n\n### Files Updated:\n- `thesis/active/DTE.DE/thesis.md` — Complete rewrite v3.0\n- `portfolio/current.yaml` — FV, last_review, exit_plan\n- `state/system.yaml` — QS entry, calendar events (thesis update + TMUS earnings), adversarial tracker", "ts": "2026-02-10T11:10:44.622507+00:00"}
{"from": "gobernator", "text": "Siguiente: actualizar la thesis de UHS (Universal Health Services). Es v2.0 del 3 de febrero, tiene earnings el 26 de febrero. Investiga novedades recientes (resultados Q3/Q4, guidance, política sanitaria US, Medicaid redetermination impact, litigios, competencia), y actualiza la thesis completa con FV revisado, QS recalculado con quality_scorer, kill conditions y preparación pre-earnings. Usa tus herramientas.", "ts": "2026-02-10T11:10:52.864304+00:00"}
{"from": "especialista", "text": "**UHS thesis v3.0 complete.** Here's the summary:\n\n---\n\n## UHS v3.0 Update Summary\n\n| Metric | v2.0 (Feb 3) | Adversarial (Feb 7) | **v3.0 (Feb 10)** |\n|--------|-------------|--------------------|--------------------|\n| Fair Value | $283.74 | $243 | **$213** |\n| MoS | 28.8% | ~10% | **~0% (NONE)** |\n| QS | 7/10 custom | 51 Tier C | **51 Tier C (confirmed)** |\n| Conviction | HOLD | LOW | **LOW - ON PROBATION** |\n\n### Key Changes\n1. **Medicaid cuts are now LAW** (One Big Beautiful Bill Act, signed Jul 4, 2025) -- $1T in cuts over 10 years, 11.8M lose coverage. UHS loses ~$360-400M/yr by 2032. This is the single biggest forward risk.\n2. **DOJ/OIG fully quantified** -- $122M settlement + 5-year Corporate Integrity Agreement constraining behavioral health (44% of revenue).\n3. **Behavioral volumes contradicting thesis** -- Q1 declined, Q2 +0.4%, Q3 +0.5%. Revenue growth is pricing-driven, not volume-driven.\n4. **DCF excluded** (0% weight) -- FCF CV=2.3 makes it unreliable. EV/EBITDA 7.0x + P/E 10x FY26E used instead.\n5. **FV $213 = price $212.94** -- Essentially zero margin of safety.\n\n### Decision: HOLD ON PROBATION through Feb 25 earnings\n- Position is small (2 shares, $403, ~3.7% of portfolio)\n- Even bear case ($190) = only -0.2% portfolio impact\n- Q3 was exceptional (+53.4% EPS) -- selling 15 days before earnings risks poor timing\n- **Post-earnings SELL/HOLD decision is MANDATORY** -- no indefinite probation\n\n### Files Updated\n- `thesis/active/UHS/thesis.md` -- Complete v3.0 rewrite (537 lines)\n- `portfolio/current.yaml` -- UHS entry updated (FV, conviction, exit_plan, last_review)\n- `state/system.yaml` -- QS entry, adversarial tracker (fase_1 + fase_2) updated\n\nThis is the 5th thesis updated today (ADBE, GL, VICI, DTE.DE, UHS). The cumulative FV revision for UHS is the deepest: **-24.9%** from original thesis.", "ts": "2026-02-10T11:18:59.425119+00:00"}
{"from": "gobernator", "text": "Última thesis v2.0 pendiente: DOM.L (Domino's Pizza Group UK). Es del 3 de febrero, tiene FY25 results el 5 de marzo con un SELL trigger si EBITDA<125M. Investiga novedades recientes (trading updates, competitive landscape UK, delivery market, food inflation trends, store count trajectory), y actualiza la thesis completa con FV revisado, QS recalculado con quality_scorer, kill conditions actualizadas y preparación pre-earnings. Usa tus herramientas.", "ts": "2026-02-10T11:24:00.155174+00:00"}
{"from": "system", "text": "RATE_LIMIT: You're out of extra usage · resets 2pm (Europe/Madrid) (failures: 1/3)", "ts": "2026-02-10T11:24:12.815879+00:00"}
{"from": "gobernator", "text": "Angel ha vendido IMB.L en eToro. Posición cerrada completamente (14.26 shares, entrada 3,066p). Actualiza el portfolio: elimina IMB.L de posiciones activas, registra la venta en transactions/decisions_log con fecha de hoy, mueve la thesis a archived/sold, y actualiza system.yaml (eliminar standing orders, kill conditions, calendar events de IMB.L). Guarda todos los cambios.", "ts": "2026-02-10T13:19:30.281413+00:00"}
{"from": "especialista", "text": "All tasks complete. Here's the summary:\n\n---\n\n## DOM.L Thesis v3.0 Complete\n\n**Fair Value: 294p → 240p (-18.4%)** — consistent with adversarial review pattern (~15-18% across all positions).\n\n### Key Changes from v2.0\n\n| Metric | v2.0 | v3.0 | Impact |\n|--------|------|------|--------|\n| FCF Conversion | 85%+ | 43-52% | **Biggest error** |\n| Store Openings | 40-50/yr | 25-35/yr | Growth engine slowed |\n| EBITDA Margin | 20-22% | 19-20% | NLW/NIC permanent drag |\n| CEO Risk | HIGH | RESOLVED | Dominic Paul (ex-Costa) |\n\n### Valuation\n- **EV/EBIT (60%)**: 253p expected value (11x FY26E EBIT £113M)\n- **P/E (40%)**: 223p expected value (12x FY26E EPS 18.5p)\n- **Weighted FV**: 240p | **MoS**: 19.2% (marginal for Tier B 20-25%)\n- DCF excluded (0% weight) — too sensitive, FCF volatile\n\n### Decision: HOLD LOW through FY25 Results March 5\n\n**SELL trigger: EBITDA < £125M** (Kill Condition #1, per your instruction)\n\nPre-earnings framework with bear/base/bull scenarios and response actions documented. New CEO Dominic Paul starts April 6 — removes the #1 overhang but introduces execution risk.\n\n### Files Updated\n- `thesis/active/DOM.L/thesis.md` — Complete v3.0 rewrite\n- `portfolio/current.yaml` — conviction, FV, exit_plan, last_review\n- `state/system.yaml` — QS entry, adversarial tracker, kill conditions, work_in_progress\n\n### Adversarial Review Status\nAll active thesis are now v3.0. Remaining: Fase 3 (standing orders BME.L, UTG.L) and Fase 5 (all-clear report).", "ts": "2026-02-10T13:32:11.803149+00:00"}
